The trial is estimated to be completed by the end of 2023
Breast cancer is the most diagnosed cancer in the UK and the second most common cause of cancer mortality in women
Singaporean startup FathomX raised US$2M funding to develop its AI model for mammograms. FanthomX aims to increase the accuracy of mammograms in breast cancer detection using...
Femtech World meets the Swiss company on a mission to enable optimal breast cancer treatment and make lasting metastasis prevention a reality. Breast cancer is the...
A new partnership aims to advance AI-enabled digital pathology for end-to-end breast tumour profiling PathPresenter, a digital pathology platform and 4D Path, a Boston company producing...
An AI medical device improves diagnostic accuracy and detects if breast cancer has metastasized to lymph nodes. Paige Breast Lymph Node is a software that has...
AI-driven software could successfully identify breast cancer missed by screenings, according to a new study The AI system Transpara can help radiologists identify potential breast cancers...
An AI tool could help spot breast cancer risk by analysing how individual breast cells behave when squeezed under stress, research suggests. Researchers at City of...
More than three million cells have been mapped, showing how breast tissue changes with age, with the biggest shifts seen during menopause. The research, described as...
A new MRI breast screening trial aims to find cancers missed by mammograms in women with average breast density. The Fast MRI Dyamond study will involve...
